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Abstract 
Background: Photodynamic therapy (PDT) using 5-aminolevulinic acid (ALA) has previously shown promising 
results in cancerous cell destruction. The present study was conducted to evaluate the efficacy of this treatment 
option on oral epithelial dysplasia in Wistar rats. Furthermore, microscopic effects of systemic versus topical admi-
nistration of ALA before laser illumination was assessed.
Material and Methods: Thirty male Wistar rats (200- 250 grams) were used in the present study. Tongue dysplasia 
was induced by a daily delivery of a 20 ppm solution of 4-nitroquinoline -1- oxide (4NQO) for 3 months. Then, 
rats were divided into 3 groups of 10 including, group 1 that was received systemic ALA-based PDT (30 mg/kg 
ALA), group 2 that was received topical ALA-based PDT (20% ALA solution) and group 3 (control) which was left 
untreated. Tongue specimens were fixed for histopathological evaluation and   dysplasia was graded at microscopic 
level. Data was compared between various treatment groups using Mann Whitney test (p<0.05). 
Results: The rate of atypical dysplastic cells was decreased significantly in both topical (p= 0.006) and systemic 
(p= 0.001) treatment groups compared to control group. Furthermore, systemic use of ALA resulted in a remarka-
ble destruction of dysplastic cells compared to its topical application (p=0.045). Nevertheless, some evidence of 
muscle destruction was documented in systemic ALA group.
Conclusions: It seems that ALA mediated PDT is an effective treatment option for the destruction of dysplastic 
cells. However, the extent of this effect depends on the mode of ALA administration before light illumination.
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Introduction
Oral epithelial dysplasia has been defined as the pre-
sence of architectural and cytological alterations with 
an increased likelihood of progression to cancer (1). 
This general term covers various stages of the disease 
from a mild alteration with basal/parabasal hyperplasia 
to carcinoma in situ (1). Currently, surgical removal is 
the accepted treatment modality for the management of 
these lesions, regardless of their grade (1, 2). Excision 
of dysplastic area would significantly decrease the risk 
of cancer progression and recurrence rate (2,3). Howe-
ver, resection treatment is very painful and may requi-
re extensive reconstructive techniques regarding the 
vast areas of oral cavity that are affected (2). In spite 
of remarkable successes in the diagnosis and grading 
of epithelial dysplasia, there is no consensus on appro-
priate treatment choices for each stage (3). Therefore, 
exploring new treatment modalities against dysplastic 
cells with less invasive and more specific operations is 
of paramount importance. Photodynamic therapy (PDT) 
is a new FDA-approved anti-cancer modality (4) which 
employs three components of photosensitizer (PS), light 
and oxygen to produces free radicals in site of PS accu-
mulation (5). The anti-tumor efficacy of PDT is illustra-
ted by 3 mechanisms: 1) direct tumor cell destruction, 2) 
anti-vascular effects and 3) induction of inflammatory 
reactions (4). Many photosensitizers have been introdu-
ced since the advent of this drug-device modality; howe-
ver, 5-aminolevulinic acid (ALA) has shown promising 
effects (6). The administration rout of ALA can be both 
topical and systemic (7). No evidence has so far been 
found to support any toxic or allergic effects for the sys-
temic use of ALA. However, it has not determined that 
which kind of ALA administration is more efficient for 
the treatment of superficial lesions by PDT. 
Recently, the treatment of non-melanoma skin cancer by 
ALA-PDT has been received much attention (7).  It has 
been reported that potentially malignant lesions like ac-
tinic keratosis are the most sensitive lesions to this treat-
ment modality (7); however, there is a lack of evidence 
concerning the efficacy of this treatment option on oral 
premalignant lesions. The present study was conducted 
to examine the efficacy of topical and systemic ALA-ba-
sed PDT in a rat experimental model of tongue epithelial 
dysplasia.
Material and Methods
-Animals
The study was conducted on male Wistar rats of 4 wee-
ks old (200-250 grams). The protocol of the study was 
approved by ethics committee of Isfahan University of 
Medical Sciences for animal care and handling, Isfahan, 
Iran (Research project number:). The initial number of 
rats was 30; however, five extra rats were later added 
to replace animals which were excluded from the study. 
The animals were kept in separate cages under standard 
conditions of humidity and temperature. Easy access to 
food and water and a 12-hour light cycle were provided 
for all rats. 
-Developing epithelial dysplasia in rats
The powder form of 4-nitroquinoline1-oxide (4NQO) 
(Sigma-Aldrich, USA) was added to rats’ water bottle 
for creating a 20 ppm solution. The water supply was 
filled with fresh water every three days. After 12 weeks, 
rats’ oral tissues, especially posterior lateral borders of 
the tongues, in the control group was inspected macros-
copically to detect clinical changes such as leukoplakia 
or erythroplakia. The dissection of the tongues was per-
formed following detection of tissue alterations based 
on clinical evidence. Then, histopathological assessment 
was carried out on both right and left sides of the ton-
gues to confirm occurrence of dysplasia in epithelium. 
Upon confirmation, the consequent steps were perfor-
med on rats in the treatment groups. We did not limit 
ourselves to this confirmation in the control group and 
adhered to exclusion criteria in the treatment groups as 
well. According to the exclusion criteria, any rat with 
a dysplasia grade of less than moderate was excluded 
from the study and replaced by another case which was 
reserved for this purpose.
-PDT mediated systemic ALA
The rats in the group 1 (systemic ALA-based PDT group) 
received 30 mg/kg ALA (Sigma Aldrich, USA) through 
intramuscular injection. Treated animals were kept in a 
dark room for 4 hours and then exposed to light illumi-
nation. Rats were superficially anesthetized through in-
halation of chloroform gas and a molt mouth gag was 
applied to open their mouth and take out their tongues 
for laser therapy. Then, visible light, with specifications 
which have summarized in table 1, was illuminated to the 
left posterior one third of lateral border of rats’ tonguesfor 
5 minutes. Other parts of the tongues were covered by an 
aluminum foil to protect them from light emitting. One 
hour after the intervention, the rats were killed painlessly 
by excessive anesthetics and their tongues were removed 
and fixed in 10% formalin for further assays. 
Parameter Amount
Power density 100 J/cm2
Power 300 mW
Time 5 min
Energy 50 J
Wave lenghth 660nm
Laser apperatus model LT/3L made in Iran
Table 1: Laser parameters.
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-PDT mediated topical ALA
An ALA solution with a concentration of 20% was pre-
pared by dissolving ALA powder (Sigma Aldrich, USA) 
into ethylene glycol oil. Rats were superficially anesthe-
tized and a swab which was impregnated with ALA so-
lution was rubbed onto the posterior one third of lateral 
border of rats’ tongues. This procedure was repeated two 
hours later. Four hours after the first ALA application, 
the tongues were exposed to visible light (with the same 
characteristics as the light used for systemic ALA treat-
ment group) for 5 minutes. Rats were killed by excessi-
ve use of anesthetics and their tongues were excised for 
fixation and histopathological assessment. 
-Histopathology examination
Samples were fixed in formalin 10% and embedded in 
paraffin for histopathological assessments.  Then sec-
tions with 5 µm thickness were stained by hematoxylin 
and eosin. Samples were assigned grades of 0-3 co-
rresponding to dysplasia severity stage (normal, mild, 
moderate, sever) through a semi-quantitative grading 
approach for cytological changes (1). Additionally, any 
evidence of vessel modification, unusual immune cell 
infiltration or tissue alterations which was not associated 
with dysplasia progression was recorded by two blinded 
expert pathologists. 
-Statistical analyzes
Cohen’s κ was run to determine if there was any disa-
greement between two pathologists. Mann Whitney test 
was used to compare stage scores between groups. The-
value of p<0.05 was considered statistically significant. 
  
Results
There was a good agreement between two pathologists’ 
reports (κ = .893). Dysplasia was graded as mild in the 
right  side of the tongue in 5 rats (3 in group 1 and 2 in 
group 2). As a result, they were excluded from the study 
and replaced by a reserved rat. Finally, a total of 35 rats 
were submitted to this investigation.
Qualitative assessment of samples in the control group 
showed a higher score of dysplasia in posterior areas of 
rats’ tongue. The grade of dysplasia in both sides of pos-
terior lateral area of rats’ tongue was almost similar in 
the control group. Severe dysplasia was observed in la-
teral posterior one third of the tongue in seven rats of the 
control group (Fig. 1a) including one sample of carcino-
ma in situ. Three cases of moderate to severe dysplasia 
were also recorded (Fig. 1b-d). Clinical features in most 
cases were presented as erythroplakia; while, in some 
cases verrucous hyperplasia of epithelium was observed. 
After light illumination, the intervened tissue was war-
mer than other sites and its appearance in most cases 
was like a necrotic tissue with a white color. The results 
showed that topical and systemic ALA-based PDT treat-
ment significantly reduced the rate of dysplasia (p<0.05) 
Fig. 1: (a) Histologic appearance of tongue epithelium with severe dysplasia in a rat of control 
group (H&E staining, ×400). (b,c,d) Moderate dysplasia and hyperkeratosis in the rats of control 
group (H&E staining, ×40).
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(Table 2). Moreover, PDT-mediated systemic ALA ad-
ministration showed more potency in the clearing of 
dysplastic cells than PDT induced by topical application 
of this photosensitizer (p=0.045). 
Signs of cell degeneration in basal and hyper-basal levels 
were observed in the most sections of the treated areas 
of rats’ tongues in both experimental groups; however, 
atrophic epithelium was also observed in samples trea-
ted by systemic ALA. 
An amorphous material was seen in microscopic assess-
ment of vascular cross sections in two rats in the group 
1 and six rats in the group 2 (Fig. 2a). Moreover, four 
cases in the group 1 showed evidence of muscle degene-
ration without any unusual infiltration of inflammatory 
cells (Fig. 2b). There was no sign of inflammatory reac-
tions in two treatment groups. 
Discussion
In the current study, we assessed the treatment of carci-
nogen induced tongue dysplasia in rats with PDT moda-
lity in combination with systemic or oral ALA. 
The method for dysplasia induction in animals was 
adapted from previous studies (10-13).  Although, all of 
these studies have been used 4NQO exposure for SCC 
P value
Epithelial 
atrophy
Muscle 
degeneration
Vessel 
changes
No. (%) of dysplastic changesIntervention
severemoderatemildWithout 
dysplasia
.00600601(10)2(20)7(70)Topical ALA-PDT
.001442001(10)9(90)Systemic ALA-PDT
-0007 (70)3 (30)00Control 
Table 2: Microscopic results in two experimental groups compared to control.
ALA-PDT: 5-aminolevulinic acid-based photodynamic therapy.
Fig. 2: (a) Histologic view of amorphous deposits developed (asterisks) in cross section of blood vessels in groups 
treated with PDT (H&E staining, ×400). (b) Muscle degeneration in a sample employed to systemic ALA admin-
istration followed by laser (H&E staining, ×100).
induction; in the current study, the use of this modality 
for about 3 months produced moderate to severe dyspla-
sia in all rats in the control group. The approach was so-
mewhat time consuming, but its efficacy was acceptable. 
To make sure of dysplasia development before the inter-
vention, tongue tissues were assessed and those without 
any evidence of dysplasia were eventually eliminated 
from the study.  
The results of the present study demonstrated that ALA-
PDT was an effective treatment in tongue dysplasia. The 
systemic mode of photosensitizer administration was 
more efficient than its topical administration mode. ALA 
is a hydrophilic compound and the rational for its topi-
cal use relies on penetration of photosensitizer through 
defective cell membrane of tumor cells (8). In early sta-
ges of dysplasia, the altered cells are covered with deep 
layers of epithelium (1). This phenomenon can explain 
why topical application of the photosensitizer in the pre-
sent study did not work as well as the systemic treat-
ment approach. The photosensitizer was dissolved in an 
oil emulsion to create potentiated penetration in cells. 
However, it seems that the excess ALA could not find its 
way into deep tissue layers and deposited on the surface 
layer. As a result, the laser beams could not reach deeper 
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layers. It is necessary to examine this hypothesis throu-
gh fluorescence imaging in future studies. It has been su-
ggested that repeated sessions of PDT mediated topical 
ALA would improve outcomes (7). 
Up to date, no evidence exists against safety of systemic 
administration of ALA, except for occasional reports of 
skin reactions against this material, which has made to 
use anesthetic drugs routinely for patients receiving this 
treatment (9). In the present study, unexpected muscle 
degeneration was reported in four rats which were recei-
ved systemic ALA. Further studies are needed to exami-
ne muscle degeneration in human subjects. Considering 
the nature of the present study, it was not possible to fo-
llow up the cases after treatment; however, according to 
Peng et al., the assessment process should continue 1-2 
months after termination of PDT sessions to evaluate the 
response in patients (7). 
In ALA-mediated PDT, the duration of photosensitizer 
application before light exposure has of great importan-
ce.  Because ALA can produce protopurphirin IX in tis-
sues during a time of 4 hours or more (7). Accordingly, 
in the present study, topical application of ALA was ca-
rried out twice with a 2-hour interval, followed by light 
exposure 4 hours after the first ALA administration. 
Present study showed 70% complete resolution of dys-
plastic tissues after topical administration of ALA and 
light emission; which is much less than the remission 
has been reported in previous published clinical studies 
(7). This may be due to different assessment procedures 
which have been applied in clinical studies compared 
to the present study. Complete resolution in clinical stu-
dieshas been determined upon clinical examinations in 
follow up sessions. However, microscopic assessment of 
resolution in the current study resulted in categorizing 
of atypical cells as dysplastic. Castano et al. reported 
that the outcome of PD is associated with the interaction 
between PS and cells of targeted tissue or tumor (8). In 
addition, it has been suggested that PS penetrates atypi-
cal cells more easily (8). As a result, it supposed that PS 
penetration improves in higher stages of dysplasia. This 
is also maybe illustrative for best results of PDT inter-
vention in SCC compared to dysplasia subjects. 
In the current study, the immediate features which were 
found in dysplastic tissues following PDT were apopto-
sis and cell destruction. The results of a study by Zaidi et 
al. were in direction with our findings (14).
In the present study, intact tissue panels or mild dysplasia 
were observed in treated tissues. It is suggested that they 
might be related to free radicals which are produced by 
PDT. Moreover, in systemic ALA-PDT group, epithelial 
atrophy was observed, which is due to the elimination of 
destroyed epithelial cells during the treatment process. 
Raised light dose in this treatment procedure improves 
tumor destruction; whereas, it is possible that it damages 
healthy tissues (15). Our findings showed that systemic 
ALA-PDT resulted in 90% (9 cases) complete resolution 
of dysplasia followed by some complications of mus-
cle degeneration and epithelial atrophy. The results of a 
study by Fink-Puches et al., indicated sever fibrosis in 
deep layers of BCC and SCC patients’ skin following 
the treatment with ALA-PDT (16). As a result, it is im-
portant to explore PDT side effects and preventive stra-
tegies for their management in future studies.  
Agostinis et al. (4) proposed three mechanisms for PDT 
efficacy in cancer treatment, including cytotoxicity, an-
ti-vascular proceed and immune cell induction. In our 
study, an amorphous material was found in cross sec-
tions of vessels. This was mainly observed in rats that 
received topical ALA-PDT treatment. More investiga-
tions are needed to identify the correlation between this 
observation and PDT effects. Our results demonstrated 
cell death and vessel changes after PDT which is in di-
rection with the results of a study by Henderson et al. 
(15). In the present study, PDT resulted in vessel occlu-
sion; whereas, vessel destruction was observed in the 
study by Henderson et al. (15). The higher energy den-
sity of Laser in the study can explain the differences in 
vessel changes following topical ALA-PDT. The impor-
tance of these two studies mostly comes from the lack 
of augmented immune response after PDT. Previous 
investigations have suggested that one mechanisms by 
which PDT creates its antitumor activities is the induc-
tion of immune cells following tumor cell destruction 
(4,8). Undetectable evidence of augmented immune res-
ponse is possibly logical in the present study because 
we could not follow our subjects like human subjects. 
Additionally, human responses to the treatment are more 
potentiated; as a result, immune cell recall after PDT im-
plementation in human subjects is much easier compa-
red to experimental animals.
The current protocol for dysplasia treatment did not co-
ver all of expectations regarding high rate of relapse and 
discomfort in experimental animals following excision 
(1). The present study also assessed the rapid changes 
in dysplastic tissues undergoing PDT. As a result, con-
sidering promising results of the current study, it is re-
commended that future studies explore optimum PDT 
parameters for the treatment of dysplasia with minimum 
side effects thought evaluating the established effects of 
this intervention on tissues in later phases.
Conclusions 
The results of the study showed that, ALA-mediated PDT 
is a successful treatment modality against oral dyspla-
sia. In addition, the systemic administration of ALA led 
to complete resolutions in more subjects compared to its 
topical administration. Further studies are needed to eva-
luate these results in human manifestation of dysplasia. 
J Clin Exp Dent. 2019;11(7):e587-92.                                                                                                                                                                              Efficacy of photodynamic therapy in dysplasia
e592
References
1. Speight PM. Update on oral epithelial dysplasia and progression to 
cancer. Head Neck Pathol. 2007;1:61-6.
2. Mehanna HM, Rattay T, Smith J, McConkey CC. Treatment and 
follow-up of oral dysplasia - a systematic review and meta-analysis. 
Head Neck. 2009;31:1600-9.
3. Zhang L, Poh CF, Lam WL, Epstein JB, Cheng X, Zhang X, et 
al. Impact of localized treatment in reducing risk of progression of 
low-grade oral dysplasia: molecular evidence of incomplete resection. 
Oral Oncol. 2001;37:505-12.
4. Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick 
SO, et al. Photodynamic therapy of cancer: an update. CA Cancer J 
Clin. 2011;61:250-81.
5. Dolmans DE, Fukumura D, Jain RK. Photodynamic therapy for can-
cer. Nat Rev Cancer. 2003;3:380-7.
6. Gold MH, Goldman MP. 5-aminolevulinic acid photodynamic the-
rapy: where we have been and where we are going. Dermatol surg. 
2004;30:1077-83; discussion 83-4.
7. Peng Q, Warloe T, Berg K, Moan J, Kongshaug M, Giercksky KE, 
et al. 5-Aminolevulinic acid-based photodynamic therapy. Clinical re-
search and future challenges. Cancer. 1997;79:2282-308.
8. Castano AP, Demidova TN, Hamblin MR. Mechanisms in photody-
namic therapy: part one-photosensitizers, photochemistry and cellular 
localization. Photodiagnosis Photodyn Ther. 2004;1:279-93.
9. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with 
endogenous protoporphyrin IX: basic principles and present clinical 
experience. J Photochem Photobiol B. 1990;6:143-8.
10. Yamamoto K, Kitayama W, Denda A, Morisaki A, Kuniyasu H, 
Kirita T. Inhibitory effects of selective cyclooxygenase-2 inhibitors, 
nimesulide and etodolac, on the development of squamous cell dyspla-
sias and carcinomas of the tongue in rats initiated with 4-nitroquinoli-
ne 1-oxide. Cancer Lett. 2003;199:121-9.
11. Tanaka T, Nishikawa A, Mori Y, Morishita Y, Mori H. Inhibitory 
effects of non-steroidal anti-inflammatory drugs, piroxicam and indo-
methacin on 4-nitroquinoline 1-oxide-induced tongue carcinogenesis 
in male ACI/N rats. Cancer Lett. 1989;48:177-82.
12. Sohrabi M, Kalati FA, Vatansever S, Abbasi MM, Roshangar L, 
Khaki AA, et al. Effect of dietary and topical Celecoxib on expression 
of bcl-2, bax, c-erb-B2 and Ki67 in carcinogen-induced tongue carci-
noma in rat. Pak J Biol Sci. 2009;12:750-7.
13. Gannot G, Buchner A, Keisari Y. Interaction between the immune 
system and tongue squamous cell carcinoma induced by 4-nitroquino-
line N-oxide in mice. Oral Oncol. 2004;40:287-97.
14. Zaidi SIA, Oleinick NL, Zaim MT, Mukhtar H. Apoptosis during 
photodynamic therapy-induced ablation of rif-1 tumors in c3h mice: 
electron microscopic, histopathologic and biochemical evidence. Pho-
tochem Photobiol. 1993;58:771-6.
15. Henderson BW, Waldow SM, Mang TS, Potter WR, Malone PB, 
Dougherty TJ. Tumor destruction and kinetics of tumor cell death in 
two experimental mouse tumors following photodynamic therapy. 
Cancer Res. 1985;45:572-6.
16. Fink-Puches R, Soyer H, Hofer A, Kerl H, Wolf P. Long-term 
follow-up and histological changes of superficial nonmelanoma skin 
cancers treated with topical δ-aminolevulinic acid photodynamic the-
rapy. Arch Dermatol. 1998;134:821-6.
Conflict of interest
The authors have declared that no conflict of interest exist.
